Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving hundreds of leading biopharmaceutical companies globally:

Generated: June 25, 2018

DrugPatentWatch Database Preview

Hetero Labs Ltd Iii Company Profile

« Back to Dashboard

What is the competitive landscape for HETERO LABS LTD III, and what generic and branded alternatives to HETERO LABS LTD III drugs are available?

HETERO LABS LTD III has twenty-eight approved drugs.

There are four tentative approvals on HETERO LABS LTD III drugs.

Summary for Hetero Labs Ltd Iii

US Patents:	0
Tradenames:	24
Ingredients:	24
NDAs:	28

Drugs and US Patents for Hetero Labs Ltd Iii

+ Get email alerts for changes to this table

This preview shows a limited data set. Subscribe for full access, or try a Free Trial
Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	TE	Type	RLD	RS	Patent No.	Patent Expiration	Product	Substance	Delist Req.	Exclusivity Expiration
Hetero Labs Ltd Iii	SIMVASTATIN	simvastatin	TABLET;ORAL	200895-001	Nov 25, 2014	AB	RX	No	No		➤ Sign Up				➤ Sign Up
Hetero Labs Ltd Iii	OSELTAMIVIR PHOSPHATE	oseltamivir phosphate	CAPSULE;ORAL	209438-003	Feb 23, 2018	AB	RX	No	No		➤ Sign Up				➤ Sign Up
Hetero Labs Ltd Iii	LEVETIRACETAM	levetiracetam	TABLET;ORAL	090515-001	Oct 8, 2010	AB	RX	No	No		➤ Sign Up				➤ Sign Up
Hetero Labs Ltd Iii	STAVUDINE	stavudine	CAPSULE;ORAL	078957-002	Dec 29, 2008	AB	RX	No	No		➤ Sign Up				➤ Sign Up
Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	TE	Type	RLD	RS	Patent No.	Patent Expiration	Product	Substance	Delist Req.	Exclusivity Expiration

Similar Applicant Names

Applicants may be listed under multiple names.
Here is a list of applicants with similar names.

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Mallinckrodt

Cantor Fitzgerald

Chinese Patent Office

Teva

Harvard Business School

Healthtrust

AstraZeneca

QuintilesIMS

UBS

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.